A Two-Dimensional Quantitative Assessment Method for Breast Ptosis Following Transaxillary Implant Augmentation
Aesthetic Plastic Surgery · 2026
DOI: 10.1007/s00266-025-05326-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Plastic Surgery, 2026. Verfasst von Hongyu Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aesthetic and Reconstructive Breast Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Col…. Hauptthemen laut MEDLINE: Breast Implantation, Patient Satisfaction, Breast Implants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Implant-only augmentation is generally considered to have limited effect in correcting breast ptosis, and standardized selection criteria are lacking. Traditional grading focuses mainly on nipple-inframammary fold (IMF) position, overlooking the inferior breast border (IBB)'s relation to the IMF. This study proposes and validates a two-dimensional quantitative assessment method-Nipple Ptosis Score (NPS) and Inferior Breast Border Ptosis Score (IBPS)-to evaluate ptosis and predict satisfaction after transaxillary implant-only augmentation. METHODS: We retrospectively analyzed patients undergoing transaxillary implant-only augmentation between June 2023 and June 2024. Preoperative and 12-month postoperative NPS and IBPS were measured. Patient satisfaction at 12 months was recorded. Correlation analysis, receiver operating characteristic (ROC) curves, and one-way ANOVA were used to assess validity, predictive accuracy, and associations with satisfaction. RESULTS: Twenty-five patients (50 breasts) were included. The method demonstrated good construct and external validity. ROC-derived cutoff scores were IBPS ≤ 1.5 (area under the curve [AUC] = 0.839) and NPS ≤ 2.5 (AUC = 0.710). ANOVA indicated that breasts meeting both thresholds achieved the highest postoperative satisfaction, whereas those meeting neither had the lowest (p < 0.001). Meeting only the IBPS threshold showed a trend toward higher satisfaction than meeting only the NPS threshold (p = 0.050). CONCLUSIONS: The two-dimensional quantitative assessment method provides an objective evaluation of breast ptosis. In Chinese women meeting implant volume requirements, preoperative IBPS ≤ 1.5 and NPS ≤ 2.5 predict higher satisfaction after transaxillary implant-only augmentation. IBPS shows stronger predictive potential for patient selection and surgical planning. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Aesthetic and Reconstructive Breast Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 33 Badachu Road, Shijingshan District, Beijing, 100144, Chin…
- Department of Aesthetic Surgery, Bravou Plastic Surgery Hospital, No. 21, Section 4, Renmin South Road, Wuhou District, Chengdu, 610000, China.
Zitieren
APA
Liang, H., Zhang, X., Liu, Y., Xu, B., Liu, W., Li, S., & Luan, J. (2026). A Two-Dimensional Quantitative Assessment Method for Breast Ptosis Following Transaxillary Implant Augmentation. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-025-05326-5
Vancouver
Liang H, Zhang X, Liu Y, Xu B, Liu W, Li S, et al. A Two-Dimensional Quantitative Assessment Method for Breast Ptosis Following Transaxillary Implant Augmentation. Aesthetic Plastic Surgery. 2026. doi:10.1007/s00266-025-05326-5
BibTeX
@article{Liang2026,
author = {Liang, Hongyu and Zhang, Xuefeng and Liu, Yue and Xu, Boyang and Liu, Wenyue and Li, Shangshan and Luan, Jie},
title = {A Two-Dimensional Quantitative Assessment Method for Breast Ptosis Following Transaxillary Implant Augmentation},
journal = {Aesthetic Plastic Surgery},
year = {2026},
doi = {10.1007/s00266-025-05326-5}
}
EUVIMED